The Indiana Centers for Applied Protein Sciences announced last week the appointment of Jean-Pierre Wery as chief scientific officer, and Lauri Caviston as vice president of business development in sales and marketing.
Prior to joining INCAPS, Wery worked at Vitae Pharmaceuticals as vice president of computational drug discovery. Before that, he worked at Eli Lilly, where his responsibilities ranged from leading the company’s effort in structural biology and computational chemistry to managing Lilly’s statistics departments.
Before joining INCAPS, Caviston worked at BD Biosciences, Corning Life Sciences, Roche Diagnostics Applied Science Group and Children’s Hospital Boston.
Samraat Raha, former vice president of GE Healthcare’s CodeLink microarray product line, has joined Agilent Technologies’ life science and chemical-analysis business unit as vice president of field operations for the Americas, according to ProteoMonitor’s sister publication, BioCommerce Week. Raha joined Amersham before the company’s acquisition by General Electric and worked there for almost two years before joining Agilent. Previously, he was chief business officer for EraGen of Madison, Wis., and prior to that, he was vice president of discovery services and bioreagents for Incyte Genomics.
Ann Reynolds has joined the board of directors of Invitrogen, the company said this week. Until 2002, she was the president of the University of Alabama at Birmingham. Prior to that, she was the chancellor of the City University of New York, and before that, chancellor of the California State University system. Reynolds holds a PhD and a master’s degree in zoology from the University of Iowa, and a bachelor’s degree in biology from Emporia State University in Kansas.